Position in CHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$158,064
+$92,765 QoQ
Shares Held
112,903
+192.2% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. CHRS ranks #268 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in CHRS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $158,064 | 112,903 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $65,299 | 38,639 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $167,524 | 117,975 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $124,759 | 76,073 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $46,666 | 63,839 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $53,169 | 65,886 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $85,325 | 61,830 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $48,560 | 46,693 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $77,744 | 44,939 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $84,246 | 35,250 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $96,921 | 29,106 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $682,417 | 182,465 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $154,424 | 36,165 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $584,655 | 85,476 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $44,249 | 5,587 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $91,871 | 9,560 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $77,539 | 10,710 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $510,576 | 39,549 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $968,963 | 60,712 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,263,121 | 140,829 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,437,238 | 248,535 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,651,622 | 249,940 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $5,592,274 | 321,765 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $7,387,222 | 402,793 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $7,010,815 | 392,543 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $6,184,505 | 381,289 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||